XML 79 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule I - Condensed Financial Information of the Registrant (Tables)
12 Months Ended
Dec. 31, 2019
Notes Tables  
Condensed Balance Sheet [Table Text Block]
   
December 31,
 
   
2019
   
2018
 
Assets
 
Current assets
     
 
     
 
Cash and cash equivalents
  $
282
    $
13,549
 
Intercompany Receivables    
8
     
 
Prepaid expenses
   
26
     
49
 
Total current assets
   
316
     
13,598
 
Investment in subsidiaries
   
134,811
     
122,972
 
Other long-term assets    
8
     
 
Total assets
  $
135,135
    $
136,570
 
                 
Liabilities and Stockholders’ Equity
 
Current liabilities
     
 
     
 
Intercompany payables
  $
1,351
    $
766
 
Total current liabilities
   
1,351
     
766
 
Total liabilities
   
1,351
     
766
 
Stockholders’ equity:
     
 
     
 
Common stock
   
355
     
353
 
Additional paid-in capital
   
371,311
     
361,628
 
Retained earnings
   
(235,474
)    
(222,403
)
Accumulated other comprehensive loss
   
(2,408
)    
(3,774
)
Total stockholders’ equity
   
133,784
     
135,804
 
Total liabilities and stockholders’ equity
  $
135,135
    $
136,570
 
Condensed Income Statement [Table Text Block]
   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
Revenue
                       
Intercompany revenue   $
8
    $
    $
 
Total Revenue
   
8
     
     
 
Operating expenses
     
 
     
 
     
 
Selling, general and administrative
   
25
    $
30
    $
286
 
Total operating expenses
   
25
     
30
     
286
 
Loss from operations
   
(17
)    
(30
)    
(286
)
Other expense (income)
                       
Equity in net loss of subsidiaries
   
(11,807
)    
16,396
     
28,302
 
Interest expense
   
     
1,383
     
16,518
 
Loss on extinguishment and modification of debt
   
     
3,037
     
 
Other (Expense) Income    
72
     
     
 
Loss before income taxes
   
(11,752
)    
(20,846
)    
(45,106
)
Income tax (expense) benefit
   
     
     
 
Net loss attributable to PlayAGS, Inc.
   
(11,752
)    
(20,846
)    
(45,106
)
Foreign currency translation adjustment
   
1,366
     
29
     
743
 
Total comprehensive loss
  $
(10,386
)   $
(20,817
)   $
(44,363
)
Condensed Cash Flow Statement [Table Text Block]
   
Year ended December 31,
 
   
2019
   
2018
   
2017
 
Cash flows from operating activities
     
 
     
 
     
 
Net loss
  $
(11,752
)   $
(20,846
)   $
(45,106
)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
                       
Amortization of deferred loan costs and discount
   
     
     
479
 
Payment-in-kind interest payments
   
     
(37,624
)    
(1,108
)
Payment-in-kind interest capitalized
   
     
     
15,933
 
Write-off of deferred loan costs and discount
   
     
3,037
     
 
Equity income from subsidiaries
   
11,807
     
16,396
     
28,302
 
Changes in assets and liabilities that relate to operations:                        
Prepaid expenses
   
23
     
5
     
(14
)
Intercompany payable/receivable
   
570
     
365
     
306
 
Accounts payable and accrued liabilities
   
     
     
(36
)
Net cash provided by (used in) operating activities
   
648
     
(38,667
)    
(1,244
)
Cash flows from investing activities                        
Investment in subsidiaries
   
(13,280
)    
(12,100
)    
(7,965
)
Distributions received from subsidiaries
   
     
     
8,084
 
Net cash (used in) provided by investing activities
   
(13,280
)    
(12,100
)    
119
 
Cash flows from financing activities
     
 
     
 
     
 
Repayment of seller notes
   
     
     
(6,870
)
Repayment of senior secured credit facilities
   
     
(115,000
)    
 
Proceeds from employees in advance of common stock issuance
   
     
     
25
 
Repurchase of shares
   
(1,320
)    
     
 
Proceeds from issuance of common stock
   
     
176,341
     
 
Proceeds from stock option exercise
   
685
     
774
     
 
Net cash (used in) provided by financing activities
   
(635
)    
62,115
     
(6,845
)
(Decrease) increase in cash and cash equivalents
   
(13,267
)    
11,348
     
(7,970
)
Cash and cash equivalents, beginning of period
   
13,549
     
2,201
     
10,171
 
Cash and cash equivalents, end of period
  $
282
    $
13,549
    $
2,201